We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: RSV vaccines and nirsevimab tied to decreased RSV-linked hospitalization
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > RSV vaccines and nirsevimab tied to decreased RSV-linked hospitalization
RSV vaccines and nirsevimab tied to decreased RSV-linked hospitalization
Health

RSV vaccines and nirsevimab tied to decreased RSV-linked hospitalization

Last updated: May 14, 2025 2:25 pm
Editorial Board Published May 14, 2025
Share
SHARE

Maternal respiratory syncytial virus (RSV) vaccination and nirsevimab have been related to a discount in RSV-associated hospitalization charges amongst infants aged 0 to 7 months in the course of the 2024–2025 RSV season, the primary season that the maternal vaccine and nirsevimab have been broadly out there, in accordance with analysis revealed within the U.S. Facilities for Illness Management and Prevention Morbidity and Mortality Weekly Report.

Monica E. Patton, M.D., from the CDC in Atlanta, and colleagues used information from the RSV-Related Hospitalization Surveillance Community (RSV-NET) and New Vaccine Surveillance Community (NVSN) to look at the affiliation between availability of maternal RSV vaccine and nirsevimab and toddler and little one RSV-associated hospitalization charges by evaluating the charges amongst kids aged youthful than 5 years for the 2024–2025 and 2018–2020 RSV seasons.

The researchers discovered that in contrast with 2018–2020 pooled charges, 2024–2025 RSV-associated hospitalization charges have been decrease amongst infants aged 0 to 7 months (eligible for defense with maternal vaccination or nirsevimab; estimated price reductions of 43 and 28% for RSV-NET and NVSN, respectively).

Infants aged 0 to 2 months had the most important estimated price discount (52 and 45% for RSV-NET and NVSN, respectively); giant reductions have been additionally seen throughout peak hospitalization intervals (December to February).

“These findings highlight the importance of effective annual health care planning to implement the Advisory Committee on Immunization Practices’ recommendations for RSV prevention products and ensure parents can protect infants as early as possible in the RSV season, either through maternal vaccination during pregnancy or infant receipt of nirsevimab,” the authors write.

“For infants born during the RSV season who are not protected through maternal vaccination, nirsevimab should be administered within the first week of life, ideally during the birth hospitalization.”

Extra data:
Monica E. Patton et al, Interim Analysis of Respiratory Syncytial Virus Hospitalization Charges Amongst Infants and Younger Kids After Introduction of Respiratory Syncytial Virus Prevention Merchandise—United States, October 2024–February 2025, MMWR. Morbidity and Mortality Weekly Report (2025). DOI: 10.15585/mmwr.mm7416a1

Quotation:
RSV vaccines and nirsevimab tied to decreased RSV-linked hospitalization (2025, Might 14)
retrieved 14 Might 2025
from https://medicalxpress.com/information/2025-05-rsv-vaccines-nirsevimab-linked-hospitalization.html

This doc is topic to copyright. Other than any truthful dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is offered for data functions solely.

You Might Also Like

Hypertension in being pregnant tied to early breastfeeding challenges and shorter feeding occasions

A shared 5 biomarker profile throughout 4 main neurodegenerative ailments

Paper-based machine detects immune defects in 10 minutes with excessive accuracy

Genetic check predicts weight problems in childhood

How precisely are racial minorities represented in US most cancers registration methods?

TAGGED:hospitalizationnirsevimabreducedRSVRSVlinkedtiedvaccines
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Carlos Mendoza finishes third for NL Supervisor of the 12 months award
Sports

Carlos Mendoza finishes third for NL Supervisor of the 12 months award

Editorial Board November 20, 2024
Past benchmarks: How DeepSeek-R1 and o1 carry out on real-world duties
From dormant to hazard: How varicella zoster virus reactivation is driving central nervous system infections
High Inflation in June Puts Pressure on Interest Rates
Instagram Faces Investigation Over Mental Health Impact on Teens

You Might Also Like

World research hyperlinks early smartphone possession with poorer psychological well being in younger adults
Health

World research hyperlinks early smartphone possession with poorer psychological well being in younger adults

July 21, 2025
Potty strain: 1 in 5 mother and father report struggles with rest room coaching
Health

Potty strain: 1 in 5 mother and father report struggles with rest room coaching

July 21, 2025
Single-food ‘mono diets’: Are they efficient, pointless, or simply plain harmful?
Health

Single-food ‘mono diets’: Are they efficient, pointless, or simply plain harmful?

July 20, 2025
Bitter melon for diabetes? Fenugreek for ldl cholesterol? The analysis behind historical treatments
Health

Bitter melon for diabetes? Fenugreek for ldl cholesterol? The analysis behind historical treatments

July 20, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?